Category: DISEASE ADVANCES - Page 2 - Start Medical Product Development

UCB announces U.S. FDA approval for ZILBRYSQ® (zilucoplan) autoinjector

October 16, 2026

ATLANTA, Oct. 20, 2026 /PRNewswire/ — UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the first self-administered once-daily autoinjector administration option for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive with ZILBRYSQ® (zilucoplan).¹ The autoinjector is designed to help simplify self-administration of ZILBRYSQ, offering patients another administration option and a more convenient treatment experience.2,3

A Blood Test That Could Detect Breast Cancer as Early as Stage I Has Started Clinical Trials

October 15, 2026

A new blood test that could lead to earlier detection and treatment of breast cancer.

Study Finds Common Chemicals May Alter Normal Breast Development

October 15, 2026

Exposure to hormone-disrupting chemicals may leave molecular changes that could someday help identify people at higher risk of breast cancer

How cell type influences the impact of cancer-related protein activity in colorectal cancer

October 15, 2026

Research has revealed that the role of an important protein in colorectal cancer may vary significantly depending on which cells it is active in. The study, published in the journal npj Precision Oncology, shows that activity of a protein called mTOR may be associated with a stronger immune response in colorectal cancer when it is active in immune cells.

Aortic root enlargement technique allows surgeons to implant heart valves at least two sizes larger

October 15, 2026

When replacing the aortic valve, a small aortic root can limit the size of the prosthetic valve that can be implanted. If the new valve is too small in relation to the patient’s body, the heart must continue to work against increased resistance—a so-called patient-prosthesis mismatch, which is associated with poorer clinical outcomes.

AI could help predict which HPV infections progress to cancer

October 15, 2026

For several decades, researchers have sought to identify biomarkers capable of accurately predicting the outcome of an infection with a high-risk oncogenic HPV type. Despite significant advances, no viral, immune-related or molecular marker can currently and reliably predict which infections will regress spontaneously and which will progress to more severe disease.

Antibody screening approach could speed development of immune-based cancer treatments

October 15, 2026

A team led by Harvard Medical School researchers at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute has developed a faster way to identify and engineer cancer-fighting therapies.

Researchers identify key pathway that drives T-cell exhaustion in cancer immunotherapy

October 15, 2026

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control.

Drug-coated balloons could offer an alternative to permanent heart stents for some patients

October 15, 2026

Thousands of heart patients could be treated without having a metal stent permanently implanted in their arteries—according to research from the University of East Anglia (UEA). A major analysis of more than 7,800 patients found that a newer treatment using drug-coated balloons performed just as well as conventional stents at preventing heart attacks and cardiovascular deaths.

How the biggest Alzheimer’s risk gene disrupts the process of insulating neurons

October 15, 2026

One of the main ways that the APOE4 gene variant, the biggest genetic risk factor for late-onset Alzheimer’s disease, undermines brain circuit function is by disrupting the process of insulating neurons with a fatty sheath that optimizes their electrical transmission.

Blog

- DISEASE ADVANCES

UCB announces U.S. FDA approval for ZILBRYSQ® (zilucoplan) autoinjector

A Blood Test That Could Detect Breast Cancer as Early as Stage I Has Started Clinical Trials

Study Finds Common Chemicals May Alter Normal Breast Development

How cell type influences the impact of cancer-related protein activity in colorectal cancer

Aortic root enlargement technique allows surgeons to implant heart valves at least two sizes larger

AI could help predict which HPV infections progress to cancer

Antibody screening approach could speed development of immune-based cancer treatments

Researchers identify key pathway that drives T-cell exhaustion in cancer immunotherapy

Drug-coated balloons could offer an alternative to permanent heart stents for some patients

How the biggest Alzheimer’s risk gene disrupts the process of insulating neurons